Reports
Sale
North America Infertility Diagnostics Devices Market Size: By Product: Equipment, Media & Consumables, Accessories; By Procedure: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Artificial Insemination, Fertility Surgeries, Others; By Patient Type: Female, Male; By Type; By End User; Regional Analysis; Supplier Landscape; 2024-2032
North America Infertility Diagnostics Devices Market Outlook
The global infertility diagnostics devices market size is expected to grow at a CAGR of 8.80% during the forecast period of 2024-2032, with North America holding a significant market share. The market is driven by the rising prevalence of infertility along with advancements in diagnostic technologies.
Key Takeaways
- In November 2023, Femasys Inc., secured an upfront investment of USD 6.85 million from PharmaCyte Biotech. The financing will support the commercialization of Femasys infertility-related products, including FemVue, which can help to check tubal infertility or blocked tubes in women. The increased access to such innovative diagnostic devices is likely to augment North America infertility diagnostics devices market share in the forecast years.
- Infertility is a common problem in the United States, with around 11% of women and 9% of men affected by this condition in their reproductive age. Rising infertility burden is likely to elevate market value in the forecast period.
- Intensive research efforts associated with infertility and its treatments are resulting in the development of advanced testing methods. This is are anticipated to boost market growth. In June 2023, researchers at the University of Alberta discovered two unique protein biomarkers that have the potential to provide a non-invasive diagnostic test for men.
North America Infertility Diagnostics Devices Market Analysis
Infertility can be defined as a condition that impairs the body’s ability to reproduce. It can be caused due to issues with the reproductive system of either the male or female partner. In women, the most common cause of infertility includes irregular ovulation, obstructed fallopian tubes, and endometriosis whereas in men, sperm disorders are the common cause of infertility issues. Factors such as lifestyle changes, delayed childbearing, and rising incidence of conditions affecting fertility are contributing to the growing cases of infertility in the region. Heightened patient awareness surrounding infertility along with the reduced stigma attached to seeking treatments for the condition are expected to significantly drive the North America infertility diagnostics devices market demand in coming years.
Rising healthcare expenditure and insurance coverage for infertility treatments in North America are positively influencing the market landscape. Moreover, the increased prevalence of infertility issues in the region directly impacts the demand for infertility diagnostic services and devices. Recent data suggests that infertility is a common problem in the United States, with around 11% of women and 9% of men of child-bearing age affected by this condition. This sharp increase in infertility burden is likely to elevate market value in the forecast period.
The rising investment in the infertility diagnostics sector to address the growing demand for advanced diagnostic solutions is expected to fuel North America infertility diagnostics devices market growth. In November 2023, Femasys Inc., a United States-based biomedical company, secured an upfront investment of USD 6.85 million from PharmaCyte Biotech (a biotechnology company headquartered in the United States). The financing will support the commercialization of Femasys infertility-related products, FemaSeed and FemVue, as well as the development of a broad portfolio of other products. FemVue, the first FDA-cleared diagnostic device for fallopian tube assessment, can help to check for tubal infertility or blocked tubes in women. The increased access to such innovative diagnostic devices is likely to augment market size in the region.
Intensive research efforts associated with infertility and its treatments are resulting in the development of advanced testing methods, which are anticipated to significantly boost North America infertility diagnostics devices market value. In June 2023, a team of researchers at the University of Alberta (a public research university in Canada) discovered two proteins that are only found in viable sperms. These unique protein biomarkers have the potential to provide men with a non-invasive diagnostic test that can offer insights into whether in vitro fertilization can work in certain patients. The development of such innovative diagnostic tests with the ability to predict the success rate of surgery in infertile men is expected to accelerate market growth in coming years.
North America Infertility Diagnostics Devices Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Equipment, Media & Consumables, Accessories |
| Procedure | In Vitro Fertilization, Intracytoplasmic Sperm Injection, Artificial Insemination, Fertility Surgeries, Others |
| Patient Type | Female, Male |
| Type | Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Cryosystems, Imaging Systems, Microscope, Others |
| End User | Hospitals & Surgical Clinics, Cryobanks, Research Institutes, Others |
| Countries | United States of America, Canada |
North America Infertility Diagnostics Devices Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Group
- Vitrolife
- Thermo Fisher Scientific
- Hamilton Thorne LTD
- Esco Micro Pte Ltd
- Genea Limited
- IVFtech APS
- FUJIFILM Irvine Scientific
- The Baker Company Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Procedure |
|
| Breakup by Patient Type |
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Infertility Diagnostics Devices Market Overview
3.1 North America Infertility Diagnostics Devices Market Historical Value (2017-2023)
3.2 North America Infertility Diagnostics Devices Market Forecast Value (2024-2032)
4 North America Infertility Diagnostics Devices Market Landscape*
4.1 North America Infertility Diagnostics Devices: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Infertility Diagnostics Devices: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Procedure
5 North America Infertility Diagnostics Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Infertility Diagnostics Devices Market Segmentation (2017-2032)
6.1 North America Infertility Diagnostics Devices Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Equipment
6.1.3 Media & Consumables
6.1.4 Accessories
6.2 North America Infertility Diagnostics Devices Market (2017-2032) by Procedure
6.2.1 Market Overview
6.2.2 In Vitro Fertilization
6.2.3 Intracytoplasmic Sperm Injection
6.2.4 Artificial Insemination
6.2.5 Fertility Surgeries
6.2.6 Others
6.3 North America Infertility Diagnostics Devices Market (2017-2032) by Patient Type
6.3.1 Market Overview
6.3.2 Female
6.3.3 Male
6.4 North America Infertility Diagnostics Devices Market (2017-2032) by Type
6.4.1 Market Overview
6.4.2 Sperm Separation Devices
6.4.3 Ovum Aspiration Pumps
6.4.4 Sperm Analyzer Systems
6.4.5 Micromanipulator Systems
6.4.6 Incubators
6.4.7 Cryosystems
6.4.8 Imaging Systems
6.4.9 Microscope
6.4.10 Others
6.5 North America Infertility Diagnostics Devices Market (2017-2032) by End User
6.5.1 Market Overview
6.5.2 Hospitals & Surgical Clinics
6.5.3 Cryobanks
6.5.4 Research Institutes
6.5.5 Others
6.6 North America Infertility Diagnostics Devices Market (2017-2032) by Countries
6.6.1 Market Overview
6.6.2 United States of America
6.6.3 Canada
7 United States of America Infertility Diagnostics Devices Market (2017-2032)
7.1 United State of America Infertility Diagnostics Devices Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Equipment
7.1.3 Media & Consumables
7.1.4 Accessories
7.2 United State of America Infertility Diagnostics Devices Market (2017-2032) by Procedure
7.2.1 Market Overview
7.2.2 In Vitro Fertilization
7.2.3 Intracytoplasmic Sperm Injection
7.2.4 Artificial Insemination
7.2.5 Fertility Surgeries
7.2.6 Others
7.3 United State of America Infertility Diagnostics Devices Market (2017-2032) by Patient Type
7.3.1 Market Overview
7.3.2 Female
7.3.3 Male
7.4 United State of America Infertility Diagnostics Devices Market (2017-2032) by Type
7.4.1 Market Overview
7.4.2 Sperm Separation Devices
7.4.3 Ovum Aspiration Pumps
7.4.4 Sperm Analyzer Systems
7.4.5 Micromanipulator Systems
7.4.6 Incubators
7.4.7 Cryosystems
7.4.8 Imaging Systems
7.4.9 Microscope
7.4.10 Others
7.5 United State of America Infertility Diagnostics Devices Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Hospitals & Surgical Clinics
7.5.3 Cryobanks
7.5.4 Research Institutes
7.5.5 Others
8 Canada Infertility Diagnostics Devices Market (2017-2032)
8.1 Canada Infertility Diagnostics Devices Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Equipment
8.1.3 Media & Consumables
8.1.4 Accessories
8.2 Canada Infertility Diagnostics Devices Market (2017-2032) by Procedure
8.2.1 Market Overview
8.2.2 In Vitro Fertilization
8.2.3 Intracytoplasmic Sperm Injection
8.2.4 Artificial Insemination
8.2.5 Fertility Surgeries
8.2.6 Others
8.3 Canada Infertility Diagnostics Devices Market (2017-2032) by Patient Type
8.3.1 Market Overview
8.3.2 Female
8.3.3 Male
8.4 Canada Infertility Diagnostics Devices Market (2017-2032) by Type
8.4.1 Market Overview
8.4.2 Sperm Separation Devices
8.4.3 Ovum Aspiration Pumps
8.4.4 Sperm Analyzer Systems
8.4.5 Micromanipulator Systems
8.4.6 Incubators
8.4.7 Cryosystems
8.4.8 Imaging Systems
8.4.9 Microscope
8.4.10 Others
8.5 Canada Infertility Diagnostics Devices Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Hospitals & Surgical Clinics
8.5.3 Cryobanks
8.5.4 Research Institutes
8.5.5 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Cook Group
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Vitrolife
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Thermo Fisher Scientific
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Hamilton Thorne LTD
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Esco Micro Pte Ltd
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Genea Limited
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 IVFtech APS
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 FUJIFILM Irvine Scientific
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 The Baker Company Inc.
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
14 North America Infertility Diagnostics Devices Market – Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The North America infertility diagnostics devices market is expected to be driven by the rising demand for the global infertility diagnostics devices market, which is anticipated to grow at a CAGR of 8.80% during the forecast period of 2024-2032, driven by the rising prevalence of infertility.
Technological advancements in infertility diagnostics and the rising healthcare expenditure are fuelling the demand for the market.
One of the significant trends in the market is rising investment in the infertility diagnostics sector. In November 2023, Femasys Inc. secured an upfront investment of USD 6.85 million from PharmaCyte Biotech. The financing will support the commercialization of Femasys infertility-related products, including FemVue, which can help to check tubal infertility or blocked tubes in women.
Based on the product, the market is segmented into equipment, media, consumables, and accessories.
Procedures available in the market include in vitro fertilization, intracytoplasmic sperm injection, artificial insemination, and fertility surgeries, among others.
By patient type, the market is divided into female and male.
The market breakup by type includes sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, and microscopes, among others.
End users include hospitals, surgical clinics, cryobanks, and research institutes, among others.
The market segmentation by countries includes the United States of America and Canada.
The key players in the market are Cook Group, Vitrolife, Thermo Fisher Scientific, Hamilton Thorne LTD, Esco Micro Pte Ltd, Genea Limited, IVFtech APS, FUJIFILM Irvine Scientific, and The Baker Company Inc.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER